Mallikarjunachari Uppuladinne V N

Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2

Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N et al. · RSC Advances · 2020 · 61 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL ^pro )

Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 54 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2

Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N et al. · PLoS ONE · 2021 · 32 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +16

Auto-regulation of Slug mediates its activity during epithelial to mesenchymal transition

Brijesh Kumar, Mallikarjunachari Uppuladinne V N, Vinod Jani et al. · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2015 · 18 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16

Drug Repurposing Studies Targeting SARS-nCoV2: An Ensemble Docking Approach on Drug Target 3C-like Protease (3CLpro)

Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N et al. · ChemRxiv · 2020 · 18 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17